Novel Inhibitors of Leukotrienes

Wo zu kaufen (2) Eigenschaften
Gesponsert
Novel Inhibitors of Leukotrienes
SpringerLink DE
160.49 EUR
Preis aktualisiert am: 13-06-2025 01:02:59
Siehe Produktangebot
Gesponsert
Novel Inhibitors of Leukotrienes
Hugendubel
213.99 EUR
Preis aktualisiert am: 07-12-2024 23:26:31
Siehe Produktangebot

Allgemein

Marke
Birkhäuser Basel

Eigenschaften

Ähnliche Produkte

Novel Inhibitors of Leukotrienes (Progress in Inflammation Research)
Novel Inhibitors of Leukotrienes (Progress in Inflammation Research)
Produkt anzeigen
Design, Synthesis, QSAR Studies of some DPP-IV Inhibitors: Design, Synthesis, QSAR studies and Biological evaluation of Novel Triazolopiperazine Based DPP-IV Inhibitors
Design, Synthesis, QSAR Studies of some DPP-IV Inhibitors: Design, Synthesis, QSAR studies and Biological evaluation of Novel Triazolopiperazine Based DPP-IV Inhibitors
Produkt anzeigen
Novel Inhibitors of Leukotrienes (Progress in Inflammation Research)
Novel Inhibitors of Leukotrienes (Progress in Inflammation Research)
Produkt anzeigen
Chagas disease. Discovery of a TcGlcK inhibitor through lead optimisation of CBZ-GlcN
Chagas disease. Discovery of a TcGlcK inhibitor through lead optimisation of CBZ-GlcN
Produkt anzeigen
Ghunaim, Mariam Jamal: Novel EGFR Targeted Compounds Against Different Types of Cancer
Ghunaim, Mariam Jamal: Novel EGFR Targeted Compounds Against Different Types of Cancer
Produkt anzeigen
Epalrestat
Epalrestat- An Aldose Reductase Inhibitor: A novel solution for the treatment of Diabetic Peripheral Neuropathy
Produkt anzeigen
Activity of the Novel BCR Kinase Inhibitor IQS019 in B-NHL
Activity of the Novel BCR Kinase Inhibitor IQS019 in B-NHL
Produkt anzeigen
Role Of Ace Inhibitor In Combination With Angiotensin Receptor Blocker: A Novel Therapeutic Approach For Ischemic Heart Disease
Role Of Ace Inhibitor In Combination With Angiotensin Receptor Blocker: A Novel Therapeutic Approach For Ischemic Heart Disease
Produkt anzeigen
Menü